David Cicurel Buys 3 Shares of Judges Scientific (LON:JDG) Stock

Judges Scientific plc (LON:JDG) insider David Cicurel bought 3 shares of the firm’s stock in a transaction on Monday, January 5th. The shares were purchased at an average price of GBX 5,753 per share, for a total transaction of £172.59.

David Cicurel also recently made the following trade(s):

• On Friday, December 5th, David Cicurel acquired 2 shares of Judges Scientific stock. The stock was bought at an average price of GBX 5,985 per share, for a total transaction of £119.70.

Judges Scientific Stock Performance

Shares of LON JDG opened at GBX 5,700 on Friday. The company has a market cap of £379.11 million, a PE ratio of 34.97, a price-to-earnings-growth ratio of 0.56 and a beta of 0.83. The company has a debt-to-equity ratio of 70.79, a current ratio of 1.97 and a quick ratio of 0.65. Judges Scientific plc has a 12 month low of GBX 4,400 and a 12 month high of GBX 9,120. The company has a 50-day simple moving average of GBX 5,467.10 and a 200-day simple moving average of GBX 6,284.70.

Trending Headlines about Judges Scientific

Here are the key news stories impacting Judges Scientific this week:

• Positive Sentiment: Multiple insiders (including David Cicurel, Bradley Ormsby, Tim Prestidge and Ian Wilcock) purchased small lots (3 shares each) at ~GBX 5,753 on Jan 5 — a signal of insider confidence but immaterial in size. MarketBeat Insider Trades
• Positive Sentiment: Brokers have reaffirmed constructive ratings (Jefferies and Berenberg reiterating buys with targets ~GBX 7,380–7,900; consensus target ~GBX 7,640), which supports upside vs. the current price. MarketBeat Analyst Notes
• Neutral Sentiment: Judges remains an acquisitive group focused on niche scientific-instrument businesses (23 subsidiaries) — a steady, long-term strategy but one that can make near-term performance dependent on acquisition timing and integration. Company Profile
• Negative Sentiment: Balance-sheet and liquidity metrics may worry investors: a high debt-to-equity (~70.8%) and a quick ratio below 1 (0.65) increase sensitivity to earnings volatility. Financial Metrics
• Negative Sentiment: Technical weakness: the share price sits below the 200‑day moving average (GBX 6,308) and near the 50‑day, which can prompt tactical selling; intraday volume above average suggests higher selling pressure today. Price & Volume Data

Wall Street Analysts Forecast Growth

JDG has been the topic of several research reports. Berenberg Bank reissued a “buy” rating and issued a GBX 7,900 price objective on shares of Judges Scientific in a research report on Wednesday, November 26th. Shore Capital restated a “house stock” rating on shares of Judges Scientific in a report on Thursday, September 18th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a GBX 7,380 price objective on shares of Judges Scientific in a research note on Tuesday, November 4th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Judges Scientific has a consensus rating of “Buy” and a consensus target price of GBX 7,640.

About Judges Scientific

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen’s Awards for innovation and export.

The Group’s companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.